A randomized phase II study of radiation induced immune boost in operable nonsmall cell lung cancer (RadImmune trial)

Hepatic arterial infusion in combination with systemic chemotherapy in patients with hepatic metastasis from colorectal cancer: A randomized phase II study – (NCT05103020) – study protocol

7 p | 3 | 3

Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: A randomized controlled trial

9 p | 13 | 2

Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study

10 p | 23 | 2

Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial

10 p | 7 | 1

Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver only colorectal metastases still unresectable after systemic induction chemotherapy – a randomized phase II study - SULTAN UCGI 30/PRODIGE 53 (NCT03164655) study protocol

11 p | 5 | 1

A randomized phase II study of weekly nabpaclitaxel plus gemcitabine or simplified LV5FU2 as first-line therapy in patients with metastatic pancreatic cancer: The AFUGEM GERCOR trial

11 p | 11 | 1

A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

7 p | 9 | 1

A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: Clinical and biological features

9 p | 14 | 0

A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer

8 p | 29 | 0